US loss of exclusivity · Cardiometabolic
Ozempic
Novo Nordisk
2032
US generics from
2025
Today: 2026
2037
2025 worldwide sales
≈$19.3B
Date basis
Company guidance
US generics
Tentatively approved
Medicare price
−71% from 2027
Pharma Patent Cliff
by readouts.io
Data checked 24 October 2026 ·
Full Ozempic timeline →